Document is current
Any future updates will be listed below
-
Authors
Kaiser, Ulrich
Vehling-Kaiser, Ursula
Kaiser, Felix
Hoffmann, Ana
Kaiser, Eleene
Fiedler, Moritz
Rechenmacher, Michael
Kaiser, Florian
-
Funding
Funding for this research was provided by:
Universitätsklinikum Regensburg
- License Information
-
More Information
Article History
Received: 9 November 2025
Accepted: 5 March 2026
First Online: 11 March 2026
Declarations
:
: The project was approved by the Ethics Committee of the University of Regensburg (No. 22-3012_1-101) and was registered in the German Register of Clinical Studies (DRKS-ID: DRKS00031613) and the Display portal of the Center for Clinical Studies of the University Hospital Regensburg (Z-2022-1734-6). Written informed consent was obtained from all participants prior to their participation in the study, in accordance with ethical standards. All approvals were granted in full compliance with the principles of the Declaration of Helsinki.
: Not applicable.
: UK, UVK, FK, AH, MF, EK, and MR declare that there is no conflict of interest. FK discloses consulting work for Abbvie, Astellas, BeiGene, Gilead, Janssen, Novartis, Pierre Fabre, Sanofi, Servier.
